Apichard Sukonthasarn Selected Research

4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamine

1/2021	Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions.
1/2020	2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network.
1/2020	Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.
1/2020	Asian management of hypertension: Current status, home blood pressure, and specific concerns in Thailand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Apichard Sukonthasarn Research Topics

Disease

9	Hypertension (High Blood Pressure) 01/2022 - 01/2020
4	Acute Coronary Syndrome 07/2021 - 09/2015
3	Masked Hypertension 01/2021 - 01/2020
3	ST Elevation Myocardial Infarction 01/2020 - 11/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2014 - 12/2011
2	Stroke (Strokes) 01/2022 - 07/2011
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 12/2011
2	Heart Failure 01/2021 - 07/2011
2	Dyslipidemias (Dyslipidemia) 01/2016 - 01/2007
2	Human Influenza (Influenza) 01/2016 - 06/2014
2	Thalassemia 01/2014 - 01/2014
2	Pulmonary Arterial Hypertension 01/2014 - 01/2014
2	Myocardial Infarction 07/2012 - 09/2007
1	Chronic Renal Insufficiency 01/2021
1	COVID-19 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Cough 01/2020
1	Dementia (Dementias) 01/2020
1	Hemorrhage 01/2014
1	Thrombocytopenia (Thrombopenia) 01/2014
1	Reperfusion Injury 07/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2011
1	Carotid Artery Diseases 12/2011
1	Hypercholesterolemia 12/2011
1	Essential Hypertension 10/2003

Drug/Important Bio-Agent (IBA)

4	oxidized low density lipoproteinIBA 07/2021 - 01/2007
4	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2021 - 01/2020
3	LipidsIBA 07/2021 - 12/2011
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2021
3	SaltsIBA 01/2021 - 01/2020
2	CholesterolIBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	CreatinineIBA 01/2020 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 01/2016
2	VaccinesIBA 06/2014 - 07/2011
2	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2014 - 01/2014
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	LDL CholesterolIBA 03/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	TroponinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Streptokinase FDA Link 01/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2016
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2015
1	Fondaparinux (Arixtra)FDA Link 09/2015
1	Hemoglobin EIBA 01/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014
1	nitroxy-butyl-acetylsalicylic acidIBA 01/2014
1	CytokinesIBA 07/2012
1	DiarylheptanoidsIBA 07/2012
1	Troponin T (Troponin T1)IBA 09/2007
1	Atorvastatin (Lipitor)FDA Link 01/2007
1	Rilmenidine (Hyperium)IBA 10/2003

Therapy/Procedure

4	Therapeutics 01/2021 - 11/2016
2	Thrombolytic Therapy 01/2020 - 11/2016
1	Blood Pressure Monitors 01/2021
1	Percutaneous Coronary Intervention 01/2020
1	Contraindications 01/2014
1	Blood Transfusion (Blood Transfusions) 01/2014
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 07/2012
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2012